000			01903 a2200517 4500
005			20250513230708.0
264		0	_c20010517
008			200105s 0 0 eng d
022			_a0006-8993
024	7		_a10.1016/s0006-8993(00)03128-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aHartlage-Rübsamen, M
245	0	0	_aRat basal forebrain cholinergic lesion affects neuronal nitric oxide synthase activity in hippocampal and neocortical target regions. _h[electronic resource]
260			_bBrain research _cJan 2001
300			_a155-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylcholinesterase _xmetabolism
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAutoradiography
650	0	4	_aBlotting, Western
650	0	4	_aCholine O-Acetyltransferase _xmetabolism
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHippocampus _xdrug effects
650	0	4	_aImmunohistochemistry
650	0	4	_aImmunotoxins _xpharmacology
650	0	4	_aInjections, Intraventricular
650	0	4	_aMale
650	0	4	_aMicroscopy, Confocal
650	0	4	_aN-Glycosyl Hydrolases
650	0	4	_aNADPH Dehydrogenase _xmetabolism
650	0	4	_aNeocortex _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase Type I
650	0	4	_aNitroarginine _xpharmacology
650	0	4	_aParasympathetic Nervous System _xcytology
650	0	4	_aProsencephalon _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aRibosome Inactivating Proteins, Type 1
650	0	4	_aSaporins
700	1		_aSchliebs, R
773	0		_tBrain research _gvol. 889 _gno. 1-2 _gp. 155-64
856	4	0	_uhttps://doi.org/10.1016/s0006-8993(00)03128-0 _zAvailable from publisher's website
999			_c11105816 _d11105816